These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 7850664
1. Evaluation of myocardial infarction therapy at a Canadian tertiary referral hospital. Leung M, Brown G, Webb J. Can J Cardiol; 1995 Jan; 11(1):43-8. PubMed ID: 7850664 [Abstract] [Full Text] [Related]
2. The management of patients who have suffered an acute myocardial infarction in a tertiary care centre. Haddad H, Searles G, Gillis A. Can J Cardiol; 2001 Feb; 17(2):179-83. PubMed ID: 11223488 [Abstract] [Full Text] [Related]
3. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice. Vermeer NS, Bajorek BV. J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236 [Abstract] [Full Text] [Related]
4. Absence of sex differences in pharmacotherapy for acute myocardial infarction. Jelinski SE, Ghali WA, Parsons GA, Maxwell CJ. Can J Cardiol; 2004 Jul; 20(9):899-905. PubMed ID: 15266360 [Abstract] [Full Text] [Related]
5. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis. van der Elst ME, Bouvy ML, de Blaey CJ, de Boer A. Clin Ther; 2005 Nov; 27(11):1806-14. PubMed ID: 16368451 [Abstract] [Full Text] [Related]
6. Acute treatment of myocardial infarction in Canada 1999-2002. Jackevicius CA, Alter D, Cox J, Daly P, Goodman S, Filate W, Newman A, Tu JV, Canadian Cardiovascular Outcomes Research Team. Can J Cardiol; 2005 Feb; 21(2):145-52. PubMed ID: 15729413 [Abstract] [Full Text] [Related]
7. Patterns of practice analysis for acute myocardial infarction. Tsuyuki RT, Gill S, Hilton JD. Can J Cardiol; 1994 Nov; 10(9):891-6. PubMed ID: 7954024 [Abstract] [Full Text] [Related]
8. Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction. Wienbergen H, Zeymer U, Gitt AK, Juenger C, Schiele R, Heer T, Towae F, Senges J, MITRA PLUS Study Group. Am J Cardiol; 2007 May 01; 99(9):1208-11. PubMed ID: 17478143 [Abstract] [Full Text] [Related]
9. Higher rates of coronary angiography and revascularization following myocardial infarction may be associated with greater survival in the United States than in Canada. The CARS Investigators (Coumadin/Aspirin Reinfarction Study). Langer A, Fisher M, Califf RM, Goodman S, O'Connor CM, Harrington RA, Fuster V. Can J Cardiol; 1999 Oct 01; 15(10):1095-102. PubMed ID: 10523476 [Abstract] [Full Text] [Related]
10. [Pharmacologic treatment of acute myocardial infarction: 2 large clinical trials at a central hospital]. Fernando PB, Ferreira A, Dias P, Moura L, Cortez M, Capucho R, Maciel MJ, Brandão F, Gomes MC. Rev Port Cardiol; 1996 Sep 01; 15(9):617-30, 611. PubMed ID: 9081315 [Abstract] [Full Text] [Related]
11. Effect of age on the use of evidence-based therapies for acute myocardial infarction. Tran CT, Laupacis A, Mamdani MM, Tu JV. Am Heart J; 2004 Nov 01; 148(5):834-41. PubMed ID: 15523314 [Abstract] [Full Text] [Related]
12. AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction. Azadpour M, Lamas GA. Expert Rev Cardiovasc Ther; 2004 Nov 01; 2(6):891-902. PubMed ID: 15500434 [Abstract] [Full Text] [Related]
14. Acute ischemic coronary artery disease and ischemic stroke: similarities and differences. Fisher M, Folland E. Am J Ther; 2008 Feb 01; 15(2):137-49. PubMed ID: 18356634 [Abstract] [Full Text] [Related]
15. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. Eagle KA, Kline-Rogers E, Goodman SG, Gurfinkel EP, Avezum A, Flather MD, Granger CB, Erickson S, White K, Steg PG. Am J Med; 2004 Jul 15; 117(2):73-81. PubMed ID: 15234641 [Abstract] [Full Text] [Related]
16. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care. Filippi A, D'Ambrosio G, Giustini SE, Pecchioli S, Mazzaglia G, Cricelli C. J Cardiovasc Med (Hagerstown); 2009 Sep 15; 10(9):714-8. PubMed ID: 19465867 [Abstract] [Full Text] [Related]
17. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry. Danchin N, Blanchard D, Steg PG, Sauval P, Hanania G, Goldstein P, Cambou JP, Guéret P, Vaur L, Boutalbi Y, Genès N, Lablanche JM, USIC 2000 Investigators. Circulation; 2004 Oct 05; 110(14):1909-15. PubMed ID: 15451803 [Abstract] [Full Text] [Related]
18. Treatment of acute myocardial infarction: does the type of hospital make a difference? PPAMI Study Group. George E, Hunsberger S, Savitha D, Pais P. Indian Heart J; 1999 Oct 05; 51(2):161-6. PubMed ID: 10407543 [Abstract] [Full Text] [Related]
20. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry]. Arós F, Loma-Osorio A, Vila J, López-Bescós L, Cuñat J, Rodríguez E, San José JM, Heras M, Marrugat J, Investigadores del PRIAMHO II. Rev Esp Cardiol; 2006 Apr 05; 59(4):313-20. PubMed ID: 16709383 [Abstract] [Full Text] [Related] Page: [Next] [New Search]